Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$967.98 USD
-10.23 (-1.05%)
Updated May 16, 2024 04:00 PM ET
After-Market: $967.74 -0.24 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $10.67 | 1.46% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $9.55 per share, missing the Zacks Consensus Estimate of $10.20 per share. This reflects a negative earnings surprise of 6.37%. Look out for REGN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $10.67 per share, reflecting a year-over-year increase of 4.2%.
Earnings History
Price & Consensus
Zacks News for REGN
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services